The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Needle-Free Drug Injection Systems-Global Market Insights and Sales Trends 2024
Synopsis
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
The global Needle-Free Drug Injection Systems market size is expected to reach US$ 16720 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Needle-Free Drug Injection Systems in various end use industries. The expanding demands from the Hospitals and Clinics, Homecare Settings, Research Laboratories and Pharmaceutical and Biotechnology companies, are propelling Needle-Free Drug Injection Systems market. Jet-Based Needle-Free Injectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Spring-Based Needle-Free Injectors segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Needle-Free Drug Injection Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Needle-Free Drug Injection Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Needle-Free Drug Injection Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Needle-Free Drug Injection Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Needle-Free Drug Injection Systems covered in this report include Antares Pharma, Inc. (US), Endo International plc (US), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (US), Valeritas, Inc. (US) and European Pharma Group (Netherland), etc.
The global Needle-Free Drug Injection Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Antares Pharma, Inc. (US)
Endo International plc (US)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (US)
Valeritas, Inc. (US)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
Global Needle-Free Drug Injection Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Needle-Free Drug Injection Systems market, Segment by Type:
Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors
Global Needle-Free Drug Injection Systems market, by Application
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Needle-Free Drug Injection Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Needle-Free Drug Injection Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
The global Needle-Free Drug Injection Systems market size is expected to reach US$ 16720 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Needle-Free Drug Injection Systems in various end use industries. The expanding demands from the Hospitals and Clinics, Homecare Settings, Research Laboratories and Pharmaceutical and Biotechnology companies, are propelling Needle-Free Drug Injection Systems market. Jet-Based Needle-Free Injectors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Spring-Based Needle-Free Injectors segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Needle-Free Drug Injection Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Needle-Free Drug Injection Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Needle-Free Drug Injection Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Needle-Free Drug Injection Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Needle-Free Drug Injection Systems covered in this report include Antares Pharma, Inc. (US), Endo International plc (US), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (US), Valeritas, Inc. (US) and European Pharma Group (Netherland), etc.
The global Needle-Free Drug Injection Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Antares Pharma, Inc. (US)
Endo International plc (US)
PharmaJet (U.S)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
INJEX Pharma AG (Germany)
National Medical Products Inc. (US)
Valeritas, Inc. (US)
European Pharma Group (Netherland)
PenJet Corporation (U.S)
Crossject SA (France)
Global Needle-Free Drug Injection Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Needle-Free Drug Injection Systems market, Segment by Type:
Jet-Based Needle-Free Injectors
Spring-Based Needle-Free Injectors
Laser-Powered Needle-Free Injectors
Vibration-Based Needle-Free Injectors
Global Needle-Free Drug Injection Systems market, by Application
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Needle-Free Drug Injection Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Needle-Free Drug Injection Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Needle-Free Drug Injection Systems Market Overview
1.1 Needle-Free Drug Injection Systems Product Overview
1.2 Needle-Free Drug Injection Systems Market Segment by Type
1.2.1 Jet-Based Needle-Free Injectors
1.2.2 Spring-Based Needle-Free Injectors
1.2.3 Laser-Powered Needle-Free Injectors
1.2.4 Vibration-Based Needle-Free Injectors
1.3 Global Needle-Free Drug Injection Systems Market Size by Type
1.3.1 Global Needle-Free Drug Injection Systems Market Size Overview by Type (2018-2029)
1.3.2 Global Needle-Free Drug Injection Systems Historic Market Size Review by Type (2018-2023)
1.3.3 Global Needle-Free Drug Injection Systems Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Needle-Free Drug Injection Systems Sales Breakdown by Type (2018-2023)
1.4.2 Europe Needle-Free Drug Injection Systems Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Needle-Free Drug Injection Systems Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Needle-Free Drug Injection Systems Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Needle-Free Drug Injection Systems Sales Breakdown by Type (2018-2023)
2 Global Needle-Free Drug Injection Systems Market Competition by Company
2.1 Global Top Players by Needle-Free Drug Injection Systems Sales (2018-2023)
2.2 Global Top Players by Needle-Free Drug Injection Systems Revenue (2018-2023)
2.3 Global Top Players by Needle-Free Drug Injection Systems Price (2018-2023)
2.4 Global Top Manufacturers Needle-Free Drug Injection Systems Manufacturing Base Distribution, Sales Area, Product Type
2.5 Needle-Free Drug Injection Systems Market Competitive Situation and Trends
2.5.1 Needle-Free Drug Injection Systems Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Needle-Free Drug Injection Systems Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Needle-Free Drug Injection Systems as of 2022)
2.7 Date of Key Manufacturers Enter into Needle-Free Drug Injection Systems Market
2.8 Key Manufacturers Needle-Free Drug Injection Systems Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Needle-Free Drug Injection Systems Status and Outlook by Region
3.1 Global Needle-Free Drug Injection Systems Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Needle-Free Drug Injection Systems Historic Market Size by Region
3.2.1 Global Needle-Free Drug Injection Systems Sales in Volume by Region (2018-2023)
3.2.2 Global Needle-Free Drug Injection Systems Sales in Value by Region (2018-2023)
3.2.3 Global Needle-Free Drug Injection Systems Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Needle-Free Drug Injection Systems Forecasted Market Size by Region
3.3.1 Global Needle-Free Drug Injection Systems Sales in Volume by Region (2024-2029)
3.3.2 Global Needle-Free Drug Injection Systems Sales in Value by Region (2024-2029)
3.3.3 Global Needle-Free Drug Injection Systems Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Needle-Free Drug Injection Systems by Application
4.1 Needle-Free Drug Injection Systems Market Segment by Application
4.1.1 Hospitals and Clinics
4.1.2 Homecare Settings
4.1.3 Research Laboratories
4.1.4 Pharmaceutical and Biotechnology companies
4.1.5 Other End Users
4.2 Global Needle-Free Drug Injection Systems Market Size by Application
4.2.1 Global Needle-Free Drug Injection Systems Market Size Overview by Application (2018-2029)
4.2.2 Global Needle-Free Drug Injection Systems Historic Market Size Review by Application (2018-2023)
4.2.3 Global Needle-Free Drug Injection Systems Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Needle-Free Drug Injection Systems Sales Breakdown by Application (2018-2023)
4.3.2 Europe Needle-Free Drug Injection Systems Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Needle-Free Drug Injection Systems Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Needle-Free Drug Injection Systems Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Needle-Free Drug Injection Systems Sales Breakdown by Application (2018-2023)
5 North America Needle-Free Drug Injection Systems by Country
5.1 North America Needle-Free Drug Injection Systems Historic Market Size by Country
5.1.1 North America Needle-Free Drug Injection Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Needle-Free Drug Injection Systems Sales in Volume by Country (2018-2023)
5.1.3 North America Needle-Free Drug Injection Systems Sales in Value by Country (2018-2023)
5.2 North America Needle-Free Drug Injection Systems Forecasted Market Size by Country
5.2.1 North America Needle-Free Drug Injection Systems Sales in Volume by Country (2024-2029)
5.2.2 North America Needle-Free Drug Injection Systems Sales in Value by Country (2024-2029)
6 Europe Needle-Free Drug Injection Systems by Country
6.1 Europe Needle-Free Drug Injection Systems Historic Market Size by Country
6.1.1 Europe Needle-Free Drug Injection Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Needle-Free Drug Injection Systems Sales in Volume by Country (2018-2023)
6.1.3 Europe Needle-Free Drug Injection Systems Sales in Value by Country (2018-2023)
6.2 Europe Needle-Free Drug Injection Systems Forecasted Market Size by Country
6.2.1 Europe Needle-Free Drug Injection Systems Sales in Volume by Country (2024-2029)
6.2.2 Europe Needle-Free Drug Injection Systems Sales in Value by Country (2024-2029)
7 Asia-Pacific Needle-Free Drug Injection Systems by Region
7.1 Asia-Pacific Needle-Free Drug Injection Systems Historic Market Size by Region
7.1.1 Asia-Pacific Needle-Free Drug Injection Systems Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Needle-Free Drug Injection Systems Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Needle-Free Drug Injection Systems Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Needle-Free Drug Injection Systems Forecasted Market Size by Region
7.2.1 Asia-Pacific Needle-Free Drug Injection Systems Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Needle-Free Drug Injection Systems Sales in Value by Region (2024-2029)
8 Latin America Needle-Free Drug Injection Systems by Country
8.1 Latin America Needle-Free Drug Injection Systems Historic Market Size by Country
8.1.1 Latin America Needle-Free Drug Injection Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Needle-Free Drug Injection Systems Sales in Volume by Country (2018-2023)
8.1.3 Latin America Needle-Free Drug Injection Systems Sales in Value by Country (2018-2023)
8.2 Latin America Needle-Free Drug Injection Systems Forecasted Market Size by Country
8.2.1 Latin America Needle-Free Drug Injection Systems Sales in Volume by Country (2024-2029)
8.2.2 Latin America Needle-Free Drug Injection Systems Sales in Value by Country (2024-2029)
9 Middle East and Africa Needle-Free Drug Injection Systems by Country
9.1 Middle East and Africa Needle-Free Drug Injection Systems Historic Market Size by Country
9.1.1 Middle East and Africa Needle-Free Drug Injection Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Needle-Free Drug Injection Systems Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Needle-Free Drug Injection Systems Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Needle-Free Drug Injection Systems Forecasted Market Size by Country
9.2.1 Middle East and Africa Needle-Free Drug Injection Systems Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Needle-Free Drug Injection Systems Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Antares Pharma, Inc. (US)
10.1.1 Antares Pharma, Inc. (US) Company Information
10.1.2 Antares Pharma, Inc. (US) Introduction and Business Overview
10.1.3 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Products Offered
10.1.5 Antares Pharma, Inc. (US) Recent Development
10.2 Endo International plc (US)
10.2.1 Endo International plc (US) Company Information
10.2.2 Endo International plc (US) Introduction and Business Overview
10.2.3 Endo International plc (US) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Endo International plc (US) Needle-Free Drug Injection Systems Products Offered
10.2.5 Endo International plc (US) Recent Development
10.3 PharmaJet (U.S)
10.3.1 PharmaJet (U.S) Company Information
10.3.2 PharmaJet (U.S) Introduction and Business Overview
10.3.3 PharmaJet (U.S) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.3.4 PharmaJet (U.S) Needle-Free Drug Injection Systems Products Offered
10.3.5 PharmaJet (U.S) Recent Development
10.4 Bioject Medical Technologies Inc. (U.S)
10.4.1 Bioject Medical Technologies Inc. (U.S) Company Information
10.4.2 Bioject Medical Technologies Inc. (U.S) Introduction and Business Overview
10.4.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Products Offered
10.4.5 Bioject Medical Technologies Inc. (U.S) Recent Development
10.5 Medical International Technology, Inc. (U.S)
10.5.1 Medical International Technology, Inc. (U.S) Company Information
10.5.2 Medical International Technology, Inc. (U.S) Introduction and Business Overview
10.5.3 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Products Offered
10.5.5 Medical International Technology, Inc. (U.S) Recent Development
10.6 INJEX Pharma AG (Germany)
10.6.1 INJEX Pharma AG (Germany) Company Information
10.6.2 INJEX Pharma AG (Germany) Introduction and Business Overview
10.6.3 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.6.4 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Products Offered
10.6.5 INJEX Pharma AG (Germany) Recent Development
10.7 National Medical Products Inc. (US)
10.7.1 National Medical Products Inc. (US) Company Information
10.7.2 National Medical Products Inc. (US) Introduction and Business Overview
10.7.3 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.7.4 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Products Offered
10.7.5 National Medical Products Inc. (US) Recent Development
10.8 Valeritas, Inc. (US)
10.8.1 Valeritas, Inc. (US) Company Information
10.8.2 Valeritas, Inc. (US) Introduction and Business Overview
10.8.3 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Products Offered
10.8.5 Valeritas, Inc. (US) Recent Development
10.9 European Pharma Group (Netherland)
10.9.1 European Pharma Group (Netherland) Company Information
10.9.2 European Pharma Group (Netherland) Introduction and Business Overview
10.9.3 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.9.4 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Products Offered
10.9.5 European Pharma Group (Netherland) Recent Development
10.10 PenJet Corporation (U.S)
10.10.1 PenJet Corporation (U.S) Company Information
10.10.2 PenJet Corporation (U.S) Introduction and Business Overview
10.10.3 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.10.4 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Products Offered
10.10.5 PenJet Corporation (U.S) Recent Development
10.11 Crossject SA (France)
10.11.1 Crossject SA (France) Company Information
10.11.2 Crossject SA (France) Introduction and Business Overview
10.11.3 Crossject SA (France) Needle-Free Drug Injection Systems Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Crossject SA (France) Needle-Free Drug Injection Systems Products Offered
10.11.5 Crossject SA (France) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Needle-Free Drug Injection Systems Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Needle-Free Drug Injection Systems Industrial Chain Analysis
11.4 Needle-Free Drug Injection Systems Market Dynamics
11.4.1 Needle-Free Drug Injection Systems Industry Trends
11.4.2 Needle-Free Drug Injection Systems Market Drivers
11.4.3 Needle-Free Drug Injection Systems Market Challenges
11.4.4 Needle-Free Drug Injection Systems Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Needle-Free Drug Injection Systems Distributors
12.3 Needle-Free Drug Injection Systems Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
